Front-face fluorescence of tetracyclines using a modulable 3D-printed platform modified with an extraction and sensing sorbent based on rare-earth metal-organic frameworks.

Laura Alcázar-Escobedo, Noelia Campillo-Tamarit, Ernesto Francisco Simó-Alfonso, Enrique Javier Carrasco-Correa

Abstract read

In one paragraph

Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Lanthanide-based luminescent metal-organic framework as an optical sensing platform for rapid and reliable assessment of antioxidant activity in food samples.Mikrochimica acta · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Laura Alcázar-EscobedoCLECEM Group, Department of Analytical Chemistry, University of Valencia, 46100, Burjassot, Valencia, Spain.

Noelia Campillo-TamaritCLECEM Group, Department of Analytical Chemistry, University of Valencia, 46100, Burjassot, Valencia, Spain.ORCID http://orcid.org/0009-0007-1660-5855

Ernesto Francisco Simó-AlfonsoCLECEM Group, Department of Analytical Chemistry, University of Valencia, 46100, Burjassot, Valencia, Spain.ORCID http://orcid.org/0000-0001-7502-6350

Enrique Javier Carrasco-CorreaCLECEM Group, Department of Analytical Chemistry, University of Valencia, 46100, Burjassot, Valencia, Spain. enrique.carrasco@uv.es.ORCID http://orcid.org/0000-0002-5580-559X

Funding

Generalitat Valenciana CIAICO/2022/183Generalitat Valenciana CIGE/2023/069Ministerio de Ciencia e Innovación PID2021-125459OB-I00

6 · The paper itself

Abstract

A stereolithographically modulable 3D-printed platform modified with a fluorescent metal-organic framework (MOF) has been developed for the selective recognition and extraction of tetracyclines, enabling their detection via front-face fluorescence spectroscopy. For this purpose, the MOF was grown in situ on the 3D-printed surface, which was previously functionalized with 2-aminoterephthalic acid, allowing the resulting composite to act as both sorptive and sensing material. Structural and morphological characterization of the MOF onto the 3D-printed device was performed using X-ray powder diffraction, scanning electron microscopy, infrared spectroscopy, and fluorescence analysis. The key advantage of the presented device is its full compatibility with conventional fluorometers, requiring no instrumental modifications since it fits directly into a standard cuvette holder. Additionally, the ability to perform measurements directly in the solid state, minimizing matrix effects thanks to the 3D-printed device functionalized with the MOF, offers a significant improvement over traditional methodologies. According to the Stern-Volmer model, the platform achieves good detection limits (1.8 and 0.5 μg L

Indexed as

3D printingFluorescent sensorMetal–organic frameworkPreconcentrationTetracyclines

Identifiers

PMID40483333

DOI10.1016/j.molstruc.2022.133768

PMCPMC12145305

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.